Resultats de la cerca - Nigel H. Russell

Refinar resultats
  1. 1
    Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia

    Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia per Alan K. Burnett, Nigel H. Russell, Robert K. Hills

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  2. 2
    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML)

    How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML) per Richard Dillon, Nicola Potter, Sylvie D. Freeman, Nigel H. Russell

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Targeting FLT3 mutations in AML: review of current knowledge and evidence

    Targeting FLT3 mutations in AML: review of current knowledge and evidence per Naval Daver, Richard F. Schlenk, Nigel H. Russell, Mark J. Levis

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

    Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution per Phennapha Klangsinsirikul, G. Ian Carter, Jenny Byrne, G Hale, Nigel H. Russell

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia

    Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia per Erica Harris, Judith Behrens, D Samson, Amin Rahemtulla, Nigel H. Russell, Jenny Byrne

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  6. 6
    The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation

    The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation per Mohamad Mohty, Rafael F. Duarte, Sandra Croockewit, Kai Hübel, Gunnar Kvalheim, Nigel H. Russell

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants

    HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants per Bronwen E. Shaw, Steven G. E. Marsh, Neema P. Mayor, Nigel H. Russell, J. Alejandro Madrigal

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation

    Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation per Nigel H. Russell, Jenny Byrne, Rowena D. Faulkner, M Gilyead, Emma Das‐Gupta, Alexandria Porcia Haynes

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy

    Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy per Sahra Ali, Gail Jones, Dominic Culligan, Philippa J. Marsden, Nigel H. Russell, Nicholas D. Embleton, Charles Craddock

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    The genotype distribution of the XRCC1gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia

    The genotype distribution of the XRCC1gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia per Claire Seedhouse, Rowena D. Bainton, Michael D. Lewis, A. Lynn Harding, Nigel H. Russell, Emma Das‐Gupta

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Granulocyte-Colony–Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke

    Granulocyte-Colony–Stimulating Factor Mobilizes Bone Marrow Stem Cells in Patients With Subacute Ischemic Stroke per Nikola Sprigg, Philip M. Bath, Liancheng Zhao, Mark Willmot, Laura J. Gray, Marion Walker, Martin Dennis, Nigel H. Russell

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

    Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial per Nigel H. Russell, Alan K. Burnett, Robert K. Hills, Sophie Betteridge, Mike Dennis, Jelena Jovanović, Richard Dillon, David Grimwade

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  13. 13
    Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

    Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Part... per Stephen Robinson, Anthony H. Goldstone, Stephen Mackinnon, Angelo Michele Carella, Nigel H. Russell, Carmen Ruiz de Elvira, Goli Taghipour, Norbert Schmitz

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission

    Curability of Patients With Acute Myeloid Leukemia Who Did Not Undergo Transplantation in First Remission per Alan K. Burnett, Anthony P. Goldstone, Robert K. Hills, Donald Milligan, Archie Prentice, John Yin, Keith Wheatley, Ann Hunter, Nigel H. Russell

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial

    Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial per Alan K. Burnett, Nigel H. Russell, Robert K. Hills, Ann E. Hunter, Lars Kjeldsen, John Liu Yin, Brenda Gibson, Keith Wheatley, Donald Milligan

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials

    No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials per Rosemary E. Gale, Teodora Popa, Melissa Wright, Naeem Khan, Sylvie D. Freeman, Alan K. Burnett, Nigel H. Russell, Robert K. Hills, David C. Linch

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  17. 17
    Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial

    Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial per Alan K. Burnett, Jamie Cavenagh, Nigel H. Russell, Robert K. Hills, Jonathan Kell, Gail Jones, Olav Wendelboe Nielsen, Asim Khwaja, Ian Thomas, Richard E. Clark

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation

    Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Bl... per Gordon Cook, Graeme Smith, Keiren Kirkland, Jungwha Lee, Rachel Pearce, Kirsty Thomson, Emma Morris, Kim Orchard, Simon Rule, Nigel H. Russell, Charles Craddock, David I. Marks

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

    Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial per Alan K. Burnett, Robert K. Hills, Donald Milligan, Lars Kjeldsen, Jonathan Kell, Nigel H. Russell, John A. Liu Yin, Ann Hunter, Anthony H. Goldstone, Keith Wheatley

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT

    Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT per David Burns, Sohail Rana, Elizabeth Martin, Sandeep Nagra, Janice Ward, Husam Osman, Andrew Bell, Paul Moss, Nigel H. Russell, Charles Craddock, Christopher P. Fox, Sridhar Chaganti

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: